Antipodes Partners’s American Express Global Business Travel GBTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-32,085
Closed -$202K – 122
2025
Q2
$202K Buy
32,085
+16,643
+108% +$107K 0.01% 63
2025
Q1
$112K Sell
15,442
-12,270
-44% -$103K ﹤0.01% 72
2024
Q4
$257K Buy
27,712
+14,828
+115% +$127K 0.01% 52
2024
Q3
$99.1K Sell
12,884
-5,252
-29% -$36.4K ﹤0.01% 62
2024
Q2
$120K Hold
18,136
– – ﹤0.01% 55
2024
Q1
$109K Buy
+18,136
New +$106K ﹤0.01% 56

Other funds holding GBTG

Antipodes Partners's GBTG Position: Q3 2025 in Review

Antipodes Partners sold out of American Express Global Business Travel (GBTG) in Q3 2025, closing a stake of 32,085 shares — an estimated $202K sold.

Antipodes Partners first reported a position in GBTG in Q1 2024 and held it in 6 quarters. The position peaked at $257K in Q4 2024. 163 funds tracked by Wall St. Rank hold GBTG as of Q3 2025.

  • Antipodes Partners reported no remaining American Express Global Business Travel position as of Q3 2025 after selling out during the quarter.
  • Antipodes Partners sold 32,085 American Express Global Business Travel shares in Q3 2025, an estimated $202K.
  • Antipodes Partners first reported a position in American Express Global Business Travel in Q1 2024 and held it in 6 quarters.
  • Antipodes Partners's American Express Global Business Travel position peaked at $257K in Q4 2024.
  • 163 funds tracked by Wall St. Rank held American Express Global Business Travel as of Q3 2025.

Based on Antipodes Partners's 13F filing for Q3 2025, filed 10 Nov 2025.